3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
11
Sarcoma
6
Neoplasms
6
Lymphoma, Mantle-Cell
6
Prostatic Neoplasms
5
Lymphoma, Non-Hodgkin
5
Rhabdomyosarcoma
4
Neoplasm Metastasis
4
Kidney Neoplasms
4
Gliosarcoma
4
Glioblastoma
4
Breast Neoplasms
4
Brain Neoplasms
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Melanoma
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Endometrial Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Liposarcoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Glioma
2
Fallopian Tube Neoplasms
2
Carcinoma, Hepatocellular
2
Interventions
Gemcitabine
7
Cisplatin
5
Ramucirumab
3
Platinum
3
Paclitaxel
3
Docetaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Carboplatin
2
rucaparib
1
pegfilgrastim
1
pazopanib
1
eribulin
1
enzalutamide
1
enfortumab vedotin
1
dehydroftorafur
1
cabozantinib
1
avelumab
1
atezolizumab
1
aflibercept
1
Taxes
1
Surgical Procedures, Operative
1
Sunitinib
1
Standard of Care
1
Specimen Handling
1
Sorafenib
1
Radiotherapy
1
Radiation
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Mitozytrex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urethral Neoplasms
×
temsirolimus
×
Clear all
No trials found.